新芝生物
(920685)
| 流通市值：6.58亿 | | | 总市值：10.51亿 |
| 流通股本：5567.65万 | | | 总股本：8887.85万 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 141,929,501.13 | 83,854,158.79 | 34,891,531.29 | 169,724,864.23 |
| 营业总成本 | 111,978,470.48 | 68,876,287.87 | 29,363,681.61 | 129,940,626.36 |
| 其他经营收益 | | | | |
| 营业利润 | 38,163,723.86 | 20,882,834.23 | 8,806,570.53 | 48,951,172.5 |
| 利润总额 | 38,117,812.35 | 20,741,550.06 | 8,812,218.71 | 48,665,496.29 |
| 净利润 | 34,555,114.41 | 18,829,136.88 | 8,279,181.27 | 43,699,136.64 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 34,555,114.41 | 18,829,136.88 | 8,279,181.27 | 43,699,136.64 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 459,503,971.72 | 419,416,165.56 | 409,357,608.68 | 422,129,130.44 |
| 非流动资产: | | | | |
| 非流动资产合计 | 261,802,390.27 | 259,093,698.91 | 257,149,592.27 | 258,444,755.19 |
| 资产总计 | 721,306,361.99 | 678,509,864.47 | 666,507,200.95 | 680,573,885.63 |
| 流动负债: | | | | |
| 流动负债合计 | 98,982,819.42 | 82,371,311.33 | 68,463,533.58 | 77,311,794.57 |
| 非流动负债: | | | | |
| 非流动负债合计 | 15,012,919.49 | 4,553,907.59 | 5,082,668.94 | 5,913,607.24 |
| 负债合计 | 113,995,738.91 | 86,925,218.92 | 73,546,202.52 | 83,225,401.81 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 573,982,706.6 | 561,682,863.51 | 565,373,066.84 | 558,415,234.93 |
| 股东权益合计 | 607,310,623.08 | 591,584,645.55 | 592,960,998.43 | 597,348,483.82 |
| 负债和股东权益合计 | 721,306,361.99 | 678,509,864.47 | 666,507,200.95 | 680,573,885.63 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 165,861,039.56 | 100,930,850.65 | 44,678,989.31 | 215,077,607.39 |
| 经营活动现金流出小计 | 151,499,183.7 | 107,141,609.65 | 57,934,358.79 | 153,946,506.77 |
| 经营活动产生的现金流量净额 | 14,361,855.86 | -6,210,759 | -13,255,369.48 | 61,131,100.62 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 664,119,421.47 | 431,878,114.06 | 111,997,202.9 | 888,902,180.23 |
| 投资活动现金流出小计 | 664,862,292.84 | 421,035,781.77 | 76,936,990.02 | 920,672,216.41 |
| 投资活动产生的现金流量净额 | -742,871.37 | 10,842,332.29 | 35,060,212.88 | -31,770,036.18 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 12,500,000 | - | - | - |
| 筹资活动现金流出小计 | 26,889,340.21 | 25,915,264.21 | 13,706,238.95 | 28,037,879.08 |
| 筹资活动产生的现金流量净额 | -14,389,340.21 | -25,915,264.21 | -13,706,238.95 | -28,037,879.08 |
| 汇率变动对现金及现金等价物的影响 | -662,483.7 | -472,097.42 | -226,855.21 | -177,192.74 |
| 现金及现金等价物净增加额 | -1,432,839.42 | -21,755,788.34 | 7,871,749.24 | 1,145,992.62 |
| 期末现金及现金等价物余额 | 95,153,076.08 | 74,830,127.16 | 104,457,664.74 | 96,585,915.5 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -21,755,788.34 | - | 1,145,992.62 |